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Background: Host genotype accounts for a component of the variability in susceptibility to childhood Plasmodium
falciparum malaria. However, despite numerous examples of host polymorphisms associated with tolerance or
resistance to infection, direct evidence for an impact of host genetic polymorphisms on the in vivo parasite
population is difficult to obtain. Parasite molecules whose expression is most likely to be associated with such
adaptation are those that are directly involved in the host-parasite interaction. A prime candidate is the family of
parasite var gene-encoded molecules on P. falciparum-infected erythrocytes, PfEMP1, which binds various host
molecules and facilitates parasite sequestration in host tissues to avoid clearance by the spleen.
Methods: To assess the impact of host genotype on the infecting parasite population we used a published parasite
var gene sequence dataset to compare var gene expression patterns between parasites from children with
polymorphisms in molecules thought to interact with or modulate display of PfEMP1 on the infected erythrocyte
surface: ABO blood group, haemoglobin S, alpha-thalassaemia, the T188G polymorphism of CD36 and the K29M
polymorphism of ICAM1.
Results: Expression levels of ‘group A-like’ var genes, which encode a specific group of PfEMP1 variants previously
associated with low host immunity and severe malaria, showed signs of elevation among children of blood group
AB. No other host factor tested showed evidence for an association with var expression.
Conclusions: Our preliminary findings suggest that host ABO blood group may have a measurable impact on the
infecting parasite population. This needs to be verified in larger studies.
Keywords: Malaria, Host polymorphisn, Parasite var geneBackground
Host genetic factors have been estimated to account for
up to 30% of the variability in the risk of developing
malaria [1]. Whereas numerous studies have examined
the effect of specific genetic polymorphisms on disease
susceptibility and severity, relatively little attention has
been paid to their direct impact on parasite gene expres-
sion patterns within the host. Such an effect may be most
pronounced on parasite molecules that play a direct role* Correspondence: george.warimwe@ndm.ox.ac.uk
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unless otherwise stated.in the host-parasite interaction. The large family of cyto-
adhesive parasite molecules called PfEMP1 (P. falciparum
erythrocyte membrane protein 1) fit this profile. These
multi-domain proteins are encoded by ~60 clonally var-
iant var genes that are present within the subtelomeric
regions of most chromosomes and within some internal
clusters. PfEMP1 are inserted into the infected erythrocyte
(IE) surface where they bind to various host ligands resul-
ting in IE sequestration in different body tissues [2]. Se-
questration of IE in tissues is thought to prevent their
passage through the spleen, where they may be effectively
removed from circulation. During the blood stage of infec-
tion by P. falciparum, individual parasites switch between
different var genes through an epigenetic mechanismral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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Through this process they can alter both the cytoadhesive
and antigenic properties of infected erythrocytes and thus
prolong infection [3,4]. We would predict that expression
of PfEMP1 by the infecting parasite population is very
sensitive to both alterations in the composition of host re-
ceptors and in the composition of the erythrocyte surface
itself. We and others have previously shown that host
immunity imposes a selection pressure on the infecting
parasite population such that a specific group of PfEMP1
variants are preferentially expressed in young children and
those with a poorly developed repertoire of IE surface
antibodies [5-7]. However, whether host genotype influ-
ences PfEMP1 expression patterns in an infecting para-
site population remains unknown. This could occur, first,
through host polymorphisms that alter the concentration
of specific PfEMP1 ligands in the body. Within this sce-
nario, polymorphisms in one host molecule may select
against expression of PfEMP1 variants requiring that mol-
ecule for cytoadhesion. Parasites expressing such variants
would therefore be left vulnerable to clearance by the
spleen while those expressing PfEMP1 variants that can
utilize other host molecules for cytoadhesion will evade
splenic clearance and dominate the infection. Second,
modification of PfEMP1 expression could occur if genetic
variants accelerate the rate at which antibodies to the
surface of IEs are acquired (this has been described for
genetic variants of haemoglobin; [8-10]). Given that host
IE surface antibodies are associated with parasite var gene
expression patterns in vivo [7], differences in the host-
PfEMP1 interaction with respect to such genotypes may
be expected.
Here, to investigate the influence of host genotype on
the infecting parasite population we compared var gene
expression patterns among clinical isolates from Kenyan
children in relation to: 1) three host polymorphisms in
molecules to which PfEMP1 binds (namely, the T188G
polymorphism of CD36 [11], the K29M polymorphism
of ICAM1 [12] and ABO blood group [13]) and, 2) two
host genetic variants of haemoglobin that accelerate the
rate at which antibodies to the surface of IEs are
acquired, alpha-thalassaemia and HbS [8-10].
Methods
Study site and participants
We used a published dataset of children presenting to
hospital with clinical malaria (N = 217) and asymptom-
atic infections (N = 33) for all the analysis presented here
[7,14]. This dataset was specifically designed to evaluate
the relationship between parasite var gene expression
patterns and immunity to clinical malaria as described
[7,14]. However various host genotype data were also
available for most children thus allowing an exploratory
analysis on the effect of host genotype on parasite vargene expression patterns. The study was carried out at
Kilifi District Hospital, situated at the coast of Kenya, fol-
lowing ethical approval by the Kenya Medical Research
Institute Ethical Review Committee. Informed consent was
obtained from parents/guardians of all study participants.
Clinical malaria was defined as fever plus ≥ 1 or more
trophozoites per 100 uninfected erythrocytes [7,14]. Se-
vere malaria was defined as a hospital admission with
any of the three major clinical syndromes that tend to
be observed in African children [15,16] namely: severe
malarial anemia (haemoglobin concentration of <5 g/dL),
impaired consciousness (Blantyre coma score <4 in pa-
tients under 8 months old or <5 in patients aged ≥ 8
months) and respiratory distress (deep ‘Kussmaul’ breath-
ing pattern). The clinical malaria patients were sampled
between August 2003 and September 2007 while children
with asymptomatic infection of any parasite density were
sampled in May 2007 during a population based cross-
sectional survey.
Host genotyping
Published methods were used for host genotyping of the
T188G polymorphism of CD36 and K29M polymorphism
of ICAM1 [17], alpha-thalassaemia [18] and HbAS [19].
ABO blood group for each patient was determined using
standard slide haemagglutination.
Parasite sampling and var sequence classification
Expressed var sequence tags were generated from cDNA
obtained from ring-stage parasite isolates obtained from
all 250 children before culture using published methods
[6]. PCR amplified var tags were ligated into plasmids
and sub-cloned into bacteria. For each parasite isolate,
up to 96 individual bacterial colonies were picked, and
plasmid DNA prepared for capillary sequencing. Sequence
assembly, classification and counting were then done
using two published analysis pipelines [7,20]. For each
parasite isolate the number of bacterial colonies carrying
cys2 var sequences and each of three previously described
cys2 sequence subgroups i.e. MFK + REY-, MFK-REY +
and MFK-REY- [6] was expressed as a percentage of the
total number of colonies sequenced and this proportion
was used for the analysis. Using another published classi-
fication approach we also classified cys2 sequences as
“group A-like” if they contained any of a set of 573 poly-
morphic sequence blocks [7,21]. For each parasite isolate
the number of colonies carrying group A-like sequences
was also expressed as a percentage of the number of
colonies sequenced.
Statistical analysis
Analysis was performed using Stata™ statistical software
version 11. Before use in linear regression models the
percentage sequence expression levels were arcsine-
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sion analysis was performed with binary variables for each
blood group phenotype, that is, blood groups A, B, AB
and O, with the latter used as the reference for compa-
rison. For all other host molecules, the respective allelic
states (i.e. heterozygous and homozygous) were used sim-
ultaneously as explanatory variables so that the results are
relative to the wild type genotype (Table 1). We tested for
an association between each polymorphism and expres-
sion levels of five markers of the parasite var gene expres-
sion profile that tend to be differentially associated with
host immunity: i) the overall proportion of expressed var
gene sequences that are classified as cys2 and, ii) the pro-
portion of cys2 var genes that fall in the MFK + REY-, iii)
MFK-REY+, iv) MFK-REY- or v) group A-like subgroup.
Our aim was to determine whether host polymorphism
have an independent effect on var gene expression and
hence all regression models were adjusted for covariates
previously found to be associated with cys2 var gene
expression levels in the primary publications on this data-
set namely: host age, IE surface antibody levels (measured
as the median IgG response to the IE surface of 8 clinical
isolates by flow cytometry) and infection type at sampling
(coded as binary variables for either mild malaria, malaria
with impaired consciousness, malaria with respiratory dis-
tress, severe malarial anemia or asymptomatic infection)
[7,14]. The validity of the observed relationships was
confirmed by checking the normality of the residuals from
the regression models. The interquartile ranges of the re-
siduals had no severe outliers thus providing no evidence
to reject normality of the residuals at a 5% alpha level.
Results and discussion
We used published var gene sequence data from 250 iso-
lates obtained from children with clinical malaria (N = 217,
of who 111 had severe malaria) or with asymptomatic in-
fection (N = 33) for this analysis ([EMBL accession num-
bers FN588437–FN592661, HE654181–HE654544]) [7,14].
The median age of the 217 children with clinical malaria
was 3 years (interquartile range (IQR) 1.8 to 4.2) while
those with asymptomatic infection had a median age of
5.4 years (IQR 4.1 to 6.7). Neither age nor IE surface anti-
bodies differed between the host polymorphisms consid-
ered here (Kruskal-Wallis test p > 0.05 for all), with the
exception of HbAS, which showed a positive association
with IE surface antibodies (Mann–Whitney U test p =
0.02) as observed in previous studies [9,10,22]. For each
host polymorphism Table 1 summarizes the number of
children with data available and their distribution. Table 2
provides a comparison of frequencies of each host poly-
morphism in our dataset with those observed in previous
studies in the same geographical setting.
Whilst the proportion of sampled var sequences broadly
classified as cys2 showed no association with any hostpolymorphism, there was evidence for an association
between elevated expression of the group A-like cys2
var subgroup and blood group AB (Beta = 0.25, 95% CI
0.07, 0.44, p = 0.008) but not with blood groups A
(Beta = −0.004, 95% CI −0.10, 0.09, p = 0.9) or B (Beta =
0.08, 95% CI −0.02, 0.19, p = 0.1) (Table 1). However, given
the number of comparisons that were performed overall
this should be considered preliminary.
Children of blood group A, B or AB tend to be more
susceptible to severe malaria than those of blood group
O [23,26]. The association between carriage of the blood
group AB and high group A-like var gene expression is
thus consistent with the fact that parasite isolates from
children with severe malaria tend to express higher
levels of group A-like var genes [7,27-29]. In our dataset,
parasite rosetting, defined as the spontaneous binding of
infected to uninfected erythrocytes, was strongly corre-
lated with group A-like var expression (N = 133, rho =
0.46, p < 0.0001; [14]). However, despite the observed
association between blood group AB and high group A-
like var expression (Table 1), among isolates with roset-
ting data available (N = 133) parasite rosetting frequency
only correlated with blood groups A (Beta = 0.12, 95%
CI 0.005, 0.24, p = 0.04) and B (Beta = 0.18, 95% CI 0.04,
0.31, p = 0.01), but not AB (Beta = 0.04, 95% CI −0.18,
0.25, p = 0.7) in a regression analysis adjusted for host
age, IE surface antibodies and infection type (also see
Figure 1). Though this may seem counterintuitive, the
lack of correlation between blood group AB and roset-
ting is not incompatible with this observation because
only a subset of group A var genes are known to pro-
mote rosetting [30] so it is quite possible that selection
for group A PfEMP1 can occur without an increase in
the rosetting phenotype. It is therefore possible that, to-
gether with age, IE surface antibodies and rosetting, the
blood group AB phenotype contributes to the in vivo se-
lection pressures that promote group A-like var gene ex-
pression in the infecting parasite population. To explore
this further, we analyzed the relationship again using the
same regression analysis framework but instead consid-
ering the blood group antigens A and B as individual al-
leles. In this analysis group A-like var gene expression
shows evidence of an association with carriage of the
blood group B antigen (Beta = 0.12, 95% CI 0.03, 0.21,
p = 0.008), but the blood group A antigen does not
(Beta = 0.03, 95% CI −0.06, 0.11, p = 0.5). The sample
size was too small to test for an interaction between these
two antigens. It is currently unclear what would drive this
selection and this observation clearly needs to be verified
in further studies.
As shown in Table 1, none of the other host poly-
morphisms considered here showed an association with
detectable alterations in patterns of parasite var gene
expression, though parasites from HbAS children had
Table 1 Relationship between host genotype and parasite var gene expression
Cys2 var group Group A-like subgroup MFK + REY- subgroup MFK-REY + subgroup MFK-REY- subgroup
Host polymorphism Type, no. in dataset Beta (95% CI), p value Beta (95% CI), p value Beta (95% CI), p value Beta (95% CI), p value Beta (95% CI), p value
ABO blood group
Blood group O, 108 0 0 0 0 0
Blood group A, 76 0.004 (−0.10, 0.11), p = 0.9 −0.004 (−0.10, 0.09), p = 0.9 −0.004 (−0.09, 0.08), p = 0.9 0.01 (−0.07, 0.09), p = 0.8 −0.01 (−0.09, 0.06), p = 0.7
Blood group B, 54 0.05 (−0.07, 0.16), p = 0.4 0.08 (−0.02, 0.19), p = 0.1 0.08 (−0.02, 0.17), p = 0.1 0.01 (−0.08, 0.09), p = 0.8 −0.01 (−0.09, 0.07), p = 0.8
Blood group AB, 12 0.13 (−0.08, 0.34), p = 0.2 0.25 (0.07, 0.44), p = 0.008 0.07 (−0.10, 0.24), p = 0.4 0.06 (−0.10, 0.21), p = 0.5 0.02 (−0.12, 0.17), p = 0.8
CD36 (T188G)
Wild type (T/T), 153 0 0 0 0 0
Heterozygous (T/G), 22 0.08 (−0.06, 0.23), p = 0.3 0.03 (−0.10, 0.15), p = 0.7 0.03 (−0.08, 0.14), p = 0.6 −0.01 (−0.12, 0.11), p = 0.9 0.07 (−0.04, 0.18), p = 0.2
Homozygous (G/G), 1 ND ND ND ND ND
ICAM1 (K29M)
Wild type (K29/K29), 79 0 0 0 0 0
Heterozygous (K29/M29), 74 −0.03 (−0.13, 0.07), p = 0.6 −0.07 (−0.16, 0.02), p = 0.1 −0.03 (−0.11, 0.05), p = 0.4 0.04 (−0.04, 0.12), p = 0.3 −0.06 (−0.14, 0.01), p = 0.1
Homozygous (M29/M29), 23 −0.05 (−0.21, 0.10), p = 0.5 −0.01 (−0.15, 0.12), p = 0.9 0.06 (−0.06, 0.17), p = 0.3 −0.07 (−0.20, 0.05), p = 0.2 −0.09 (−0.20, 0.03), p = 0.1
HbS
Wild type (HbAA), 198 0 0 0 0 0
Heterozygous (HbAS), 12 −0.19 (−0.40, 0.01), p = 0.07 −0.18 (−0.37, 0.01), p = 0.07 −0.08 (−0.25, 0.09), p = 0.4 −0.08 (−0.25, 0.08), p = 0.3 −0.10 (−0.25, 0.05), p = 0.2
Homozygous (HbSS), 1 ND ND ND ND ND
Alpha-thalassaemia
Wild type (αα/αα), 77 0 0 0 0 0
Heterozygous (−α/αα), 106 0.10 (−0.001, 0.20), p = 0.05 0.06 (−0.03, 0.16), p = 0.2 0.07 (−0.01, 0.15), p = 0.08 −0.01 (−0.09, 0.07), p = 0.8 0.04 (−0.03, 0.11), p = 0.3
Homozygous (−α/-α), 31 0.03 (−0.11, 0.18), p = 0.6 0.02 (−0.11, 0.16), p = 0.7 0.03 (−0.09, 0.14), p = 0.6 −0.05 (−0.17, 0.06), p = 0.3 0.06 (−0.04, 0.17), p = 0.2
Results from linear regression models predicting var expression levels using the various host polymorphisms are shown. In the case of ABO blood groups, binary variables for blood group A, B and AB were used
simultaneously as explanatory variables such that the results are presented relative to blood group O. For the CD36 T188G polymorphism, the ICAM1 K29M polymorphism and alpha-thalassaemia both the
heterozygous and homozygous allelic states were used simultaneously as explanatory variables such that the results are relative to the wild type of each host molecule. ND, not done.
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Table 2 Summary of host polymorphism frequencies in
the study
Host
polymorphism
Allelic states Frequency
in dataset
(%)
Frequency in
previous studies
(Reference)
ABO blood
group
Blood group O 108 (43.2%) 44.7% [23]
Blood group A 76 (30.4%) 25.5% [23]
Blood group B 54 (21.6%) 20.2% [23]
Blood group AB 12 (4.8%) 9.6% [23]
CD36 (T188G)
Wild type (T/T) 153 (86.9%) 83.5% [11]
Heterozygous (T/G) 22 (12.5%) 15.6% [11]
Homozygous (G/G) 1 (0.6%) 0.9% [11]
ICAM1 (K29M)
Wild type (K29/K29) 79 (44.9%) 45% [12]
Heterozygous (K29/M29) 74 (42.0%) 44% [12]
Homozygous (M29/M29) 23 (13.1%) 11% [12]
HbS
Wild type (HbAA) 198 (93.8%) 91.8% [24]
Heterozygous (HbAS) 12 (5.7%) 7.7% [24]
Homozygous (HbSS) 1 (0.5%) 0.5% [24]
Alpha-
thalassaemia
Wild type (αα/αα) 77 (36.0%) 35% [25]
Heterozygous (−α/αα) 106 (49.5%) 48% [25]
Homozygous (−α/-α) 31 (14.5%) 17% [25]
The proportion of children with each host polymorphism in the present study
is compared to proportions observed in previous studies in the same
geographical setting and the respective publications indicated.
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var subgroup when compared to those from children
with wild type hemoglobin (Table 1). The homozygous
states of HbS and the CD36 T188G polymorphism were
poorly represented in this dataset (one child each) and
hence their effect on parasite var gene expression was not
formally assessed.
Previous studies have noted the abnormal display of
PfEMP1 on the surface of infected erythrocytes fromO A AB B
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Figure 1 Parasite group A-like var expression and rosetting in childre
group A-like var expression and blood group (A) and the distribution of pa
blood groups is shown. The data in both (A) and (B) represent isolates from
and the mean and standard errors of the mean are shown for each ABO bHbAS individuals that correlates with poor endothelial
binding properties of such IE, perhaps providing a me-
chanical basis for the malaria-protective effect of HbAS
[31,32]. In our analysis HbAS children had high IE sur-
face antibody levels (see above) and notably low group
A-like var expression levels though this latter observa-
tion did not reach the conventional level of statistical
significance (Beta = −0.18, 95% CI −0.37, 0.01, p = 0.07;
see Table 1). However, removal of IE surface antibodies
as a covariate in the regression modeling strengthened
this inverse relationship between HbAS and group A-
like var expression (Beta = −0.21, 95% CI −0.41, −0.02,
p = 0.03). The possibility that low group A-like var
expression levels in HbAS children results from the en-
hanced IE surface antibody response associated with this
host genotype clearly needs further study. Future studies
with better host genotype representation also need to
consider the poorly understood host-parasite relation-
ship among children with sickle cell disease (HbSS), a
major risk factor for death from malaria [24], as well as
the known negative epistasis in the malaria-protective
effects of HbAS and alpha-thalassaemia [19].
Finally, we predicted an association between parasite
var gene expression and polymorphisms in ICAM1 and
CD36 based on the hypothesis that the reduced in vivo
concentration of these host ligands resulting from the
polymorphisms would give a growth advantage to para-
sites expression PfEMP1 that can bind to different host
ligands. The lack of an association between these poly-
morphisms and group A-like var expression seems incon-
sistent with previous observations that group A PfEMP1
tend to bind poorly to ICAM1 and CD36 [33,34]. How-
ever our observation is consistent with previous studies in
which the cytoadhesion phenotype of parasites sampled
from children was compared in individuals with these po-
lymorphisms [35,36]. Furthermore, a recent study showsB
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n of different blood groups. The relationship between parasite
rasite rosetting frequencies in isolates from children of different ABO
each of 133 children whose parasite rosetting data were available,
lood group.
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this association less easy to predict [37]. We also note that
the proportion of expressed group A-like var sequences in
the isolate from the only CD36 T188G homozygote in our
dataset (12.7%) was below the lower 95% confidence inter-
val of the mean expression levels in isolates from hetero-
zygote (mean = 26.1%, 95% CI 15.4%, 36.9%) and wild type
children (mean = 24.1%, 95% CI 20.4%, 27.8%). This may
suggest that the effect of this host polymorphism on para-
site var expression is only evident among homozygotes.
Further studies with more T188G CD36 homozygotes are
needed to test this.
Conclusions
In summary, despite sample size limitations for all host
factors considered here, our preliminary evidence suggests
that host genotype has a potential role in influencing var
gene expression patterns in the infecting parasite popula-
tion. More studies with the primary aim of evaluating the
effect of host genotype on the whole parasite transcrip-
tome could be a useful approach to validating and under-
standing mechanisms of host resistance and tolerance to
P. falciparum infection.
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